Madrigal Pharmaceuticals, Inc. MDGL Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number

Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number at other companies

MSCIMSCI

410K-15.5%

Arthur J. GallagherAJG

4.1M—

PPG IndustriesPPG

714.1K+10.8%

RBC BearingsRBC

46.1K+3.9%

General MotorsGM

15M+29.3%

Otis WorldwideOTIS

1.9M+5.8%

Other financials

Income statement

See full

Revenue$311.3M+127%

Gross profit$43.5M—

Operating income-$92.7M-16.9%

Net income-$94.4M-28.9%

EPS (diluted)-$3.25-24.5%

Balance sheet

See full

Cash & equivalents$232.2M+23.1%

Total debt$377.3M+187%

Total equity$543.5M-23.5%

Total assets$1.2B+23.1%

Cash flow

See full

Operating cash flow-$167.4M-88.4%

CapEx$3.8M—

Free cash flow-$171.3M-92.7%

Valuation

See full

Market cap$11.66B+64.2%

Enterprise value$11.81B+67.5%

P/S10.3×-12.1×

Profitability

See full

Gross margin96.5%—

Operating margin-27.7%-12.2pp

Net margin-27.3%-12.0pp

FCF margin-59.8%-29.6pp

Returns & leverage

See full

Return on equity-49.3%-0.8pp

Debt / equity0.7×+0.5×

Current ratio3.5×-2.4×

Where this comes from

Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.

The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Madrigal Pharmaceuticals, Inc.'s share based compensation arrangement by share based payment award options exercisable number.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Madrigal Pharmaceuticals, Inc.'s share based compensation arrangement by share based payment award options exercisable number?: Madrigal Pharmaceuticals, Inc. (MDGL) reported share based compensation arrangement by share based payment award options exercisable number of $716.13K in Q1 2026.
How has Madrigal Pharmaceuticals, Inc.'s share based compensation arrangement by share based payment award options exercisable number changed year-over-year?: Madrigal Pharmaceuticals, Inc.'s share based compensation arrangement by share based payment award options exercisable number decreased by 37.8% year-over-year, from $1.15M to $716.13K.